Condition: Gastric Cancer Stage II · Gastric Cancer Stage III · Sponsor: The Affiliated Hospital of Qingdao University
To evaluate the clinical efficacy of robot radical Gastrectomy and laparoscopic radical Gastrectomy, patients with gastric adenocarcinoma (cT2N+M0 or cT3-4a/N+M0, phase II and III) undergoing neoadjuvant treatment were selected as subjects.
This description comes directly from the study's public registry record.
Yanbing Zhou · 13708971773 · zhouyanbing999@aliyun.com
Always discuss trial participation with your own doctor first.
| Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital | Qingdao, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06042998